CASP3 and colorectal carcinoma: These results are in agreement with previous CRC subcutaneous xenograft models, wherein 1,4-dihydroxy quininib did not significantly alter Ki-67 (p = 0.09) or cleaved caspase-3 (p = 0.10) expression (29).